Surgical treatment of locally advanced kidney cancer in the T3a–с stage

Abstract

BACKGROUND: Kidney cancer is a common pathologic condition, which ranks the 3rd place among urologic cancers. In 4–10% of patients, while growing it metastasizes upward the venous vessels up to the thoracic vena cava and right atrium. Selection of the optimal tactics for surgical treatment of such patients still remains a complex and unsolved task.

AIM: To assess the surgical treatment findings for the patients suffered from kidney cancer with tumor invasion in the renal and inferior vena cava.

MATERIALS AND METHODS: 115 patients with renal cell carcinoma complicated by tumor invasion into renal and inferior vena cava have been operated in North-Western State Medical University named after I.I. Mechnikov from 2003 to 2023. They were 76 (66.1%) men and 39 (33.9%) women, their mean age was 67.0 ± 4.1. Stage T3a covered 53 (46.1%), T3b — 33 (28.7%) and T3c 29 (25.2%) patients. Metastatic lesion of one lymph node was observed in 21 (18.3%) and of multiple nodes in 6 (5.2%) patients. Distant metastases were found in 26 (22.6%) patients: in the lungs in 9.6% and in the adrenal glands in 5.2%. All patients were treated with radical nephrectomy, removing blood trombi from the inferior vena cava system. Eight (7.0%) of them, received the treatment by the method developed in the clinic, which consists in preliminary endovascular extraction of the cranial trombus part. Another 3 (2.6%) patients were treated using cardiopulmonary bypass machine.

RESULTS: Early postoperative complications developed in 36 (31.4%) patients. The most common and severe of them were pulmonary embolism (4.4%) and acute cardiovascular insufficiency (10.4%). These complications appeared the causes of death of 4 patients. The mortality rate was 3.5%. The three year survival rate in the T3a group was 70.6%, T3b group — 66.0% and T3c group — 50.6% (p < 0.05).

CONCLUSIONS: Nephrectomy with vena cava thrombectomy is a radical surgical treatment. Its complexity increases as the tumor thrombus spreads further through the venous system and in some cases requires an interdisciplinary approach.

Keywords

kidney cancer / inferior vena cava / tumor venous thrombosis

References

[1] Axel E.M., Matveev V.B. Statistics of malignant tumors of the urinary and male reproductive organs in Russia and the former USSR // Onkourologiya = Cancer Urology. – 2019. - Vol. 15, No. 2. – P. 15–24. DOI: 10.17650/1726-9776-2019-15-2-15-24 EDN: VMMGKE

[2] Аксель Е.М., Матвеев В.Б. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР // Онкоурология. 2019. Т. 15, № 2. С. 15–24. EDN: VMMGKE doi: 10.17650/1726-9776-2019-15-2-15-24

[3] Axel EM, Matveev VВ. Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR. Cancer Urology. 2019;15(2):15–24. EDN: VMMGKE doi: 10.17650/1726-9776-2019-15-2-15-24

[4] Volkova M.I., Vashakmadze N.L., Klimov A.V., et al. Prognosis of operated patients with kidney cancer and tumor venous thrombosis: experience from the Urology Clinic of the N.N. Blokhin National Medical Research Center of Oncology // Onkourologiya = Cancer Urology. - 2021. - Vol. 17, No. 3. - P. 19-28. DOI: 10.17650/1726-9776-2021-17-3-19-28 EDN: VDSSGG

[5] Волкова М.И., Вашакмадзе Н.Л., Климов А.В., и др. Прогноз оперированных больных раком почки с опухолевым венозным тромбозом: опыт клиники урологии НМИЦ онкологии им. Н.Н. Блохина // Онкоурология. 2021. Т. 17, № 3. С. 19–28. EDN: VDSSGG doi: 10.17650/1726-9776-2021-17-3-19-28

[6] Volkova MI, Vashakmadze NL, Klimov AV, et al. Prognosis of patients operated on for renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinics, N.N. Blokhin National Medical Research Center of Oncology. Cancer Urology. 2021;17(3):19–28. EDN: VDSSGG doi: 10.17650/1726-9776-2021-17-3-19-28

[7] Davydov M.I., Matveev V.B., Volkova M.I. et al. Surgical treatment of Renal Cell Carcinoma (RCC) with level III–IV tumor venous thrombosis // Onkourologiya = Cancer Urology. – 2016. – Vol. 12, No. 4. – P. 21-34. DOI: 10.17650/1726-9776-2016-12-4-21-34 EDN: ZEORLD

[8] Давыдов М.И., Матвеев В.Б., Волкова М.И., и др. Хирургическое лечение рака почки, осложненного опухолевым венозным тромбозом III–IV уровней // Онкоурология. 2016. Т. 12, № 4. С. 21–34. EDN: ZEORLD doi: 10.17650/1726-9776-2016-12-4-21-34

[9] Davydov MI, Matveev VB, Volkova MI, et al. Surgical treatment of Renal Cell Carcinoma (RCC) with level III–IV tumor venous thrombosis. Cancer Urology. 2016;12(4):21–34. EDN: ZEORLD doi: 10.17650/1726-9776-2016-12-4-21-34

[10] Komyakov B.K., Zamyatnin S.A., Tsygankov A.V., Salsanov A.T. Our experience in the surgical treatment of kidney cancer complicated by tumor venous invasion // Urologicheskie vedomosti. - 2015. - Vol. 5, No. 1. - P. 20-21. EDN: TRSFUP

[11] Комяков Б.К., Замятнин С.А., Цыганков А.В., Салсанов А.Т. Наш опыт хирургического лечения рака почки, осложненного опухолевой венозной инвазией // Урологические ведомости. 2015. Т. 5, № 1. С. 20–21. EDN: TRSFUP doi: 10.17816/uroved5120-21

[12] Komyakov BK, Zamyatnin SA, Tsygankov AV, Salsanov AT. Nash opyt khirurgicheskogo lecheniya raka pochki, oslozhnennogo opukholevoy venoznoy invaziey. Urology reports (St. Petersburg). 2015;5(1):20–21. EDN: TRSFUP doi: 10.17816/uroved5120-21

[13] Alekseyev B.Ya., Anzhiganova Yu.V., Lykov A.V. et al. Some specific features of the diagnosis and treatment of kidney cancer in Russia: preliminary results of a multicenter cooperative study // Onkourologiya = Cancer Urology. – 2012. - No. 3. – P. 24–30. EDN: PTTFJH

[14] Алексеев Б.Я., Анжиганова Ю.В., Лыков А.В., и др. Особенности диагностики и лечения рака почки в России: предварительные результаты многоцентрового кооперированного исследования // Онкоурология. 2012. Т. 8, № 3. С. 24–30. EDN: PTTFJH doi: 10.17650/1726-9776-2012-8-3-24-30

[15] Alekseev BYa, Anzhiganova YuV, Lykov AV, et al. Some specific features of the diagnosis and treatment of kidney cancer in Russia: preliminary results of a multicenter cooperative study. Cancer Urology. 2012;8(3):24–30. EDN: PTTFJH doi: 10.17650/1726-9776-2012-8-3-24-30

[16] Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68(6):394−424. DOI: 10.3322/caac.21492

[17] Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2018. Vol. 68, N 6. P. 394–424. doi: 10.3322/caac.21492

[18] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492

[19] Roussel E., Verbiest A., Milenkovic U., et al. The Role of Cytoreductive Nephrectomy in the Contemporary Management of Metastatic Kidney Cancer. The Journal of Urology. 2020;203(Suppl 4):e 200. DOI:10.1097/JU.0000000000000839.013

[20] Roussel E., Verbiest A., Milenkovic U., et al. The role of cytoreductive nephrectomy in the contemporary management of metastatic kidney cancer // J Urol. 2020. Vol. 203, N S4. P. e200–e200. doi: 10.1097/JU.0000000000000839.013

[21] Roussel E, Verbiest A, Milenkovic U, et al. The role of cytoreductive nephrectomy in the contemporary management of metastatic kidney cancer. J Urol. 2020;203(S4):e200–e200. doi: 10.1097/JU.0000000000000839.013

[22] Kaprin A.D., Starinsky V.V., Petrova G.V. (Eds.). Malignant neoplasms in Russia in 2018 (incidence and mortality). // Moscow: P.A. Hertsen Moscow Oncology Research Institute − Branch of the Federal State Budgetary Institution "National Medical Research Center for Radiology" of the Ministry of Health of Russia, 2019. − 250 p.

[23] Злокачественные новообразования в России в 2018 году (заболеваемость и смертность) / под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. Москва: МНИОИ им. П.А. Герцена, 2019. 250 с.

[24] Kaprin AD, Starinsky BB, Petrova GV, editors. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow: P.A. Herzen MNIOI; 2019. 250 p. (In Russ.)

[25] Komyakov B.K., Zamyatnin S.A., Arkhangelsky A.I., Zubarev V.A., Salsanov A.T. Analysis of the results of surgical treatment of patients with renal cell carcinoma with tumor invasion into the renal and inferior vena cava // Preventive and Clinical Medicine. - 2018. - No. 2(67). - P. 56-61. EDN: XWTOIH

[26] Комяков Б.К., Замятнин С.А., Архангельский А.И., и др. Анализ результатов оперативного лечения больных почечно-клеточным раком с опухолевой инвазией в почечную и нижнюю полую вену // Профилактическая и клиническая медицина. 2018. № 2. С. 56–61. EDN: XWTOIH

[27] Komyakov BK, Zamyatnin SA, Archangelskiy AI, et al. The analysis of the results of surgical treatment of renal cell carcinoma with tumor invasion in the renal and inferior vena cava. Preventive and clinical medicine. 2018;(2):56–61. EDN: XWTOIH

[28] Komyakov B.K., Matveev V.B., Salsanov A.T. Combined surgical intervention for kidney cancer at stage T3c // In: Proceedings of the XXII Congress of the Russian Society of Urologists. Collection of abstracts. – Moscow: 2022. – P. 277.

[29] Комяков Б.К., Матвеев В.Б., Салсанов А.Т. Комбинированное хирургическое вмешательство при раке почки в стадии T3с. В кн.: Сборник тезисов материалов ХХII Конгресса Российского общества урологов. Москва, 2022. С. 277.

[30] Komyakov BK, Matveev VB, Salsanov AT. Комбинированное хирургическое вмешательство при раке почки в стадии T3с. In: Proceeding thesis of the ХХII Congress of the Russian Society of Urology. Moscow; 2022. P. 277. (In Russ.)

RIGHTS & PERMISSIONS

Eco-Vector